Women with PCOS face a 2.8-fold higher risk for obesity and a 1.7-fold higher risk for central obesity compared with individuals without PCOS ( AOMs, including liraglutide and semaglutide, combined with lifestyle intervention could offer an upgraded treatment strategy for patients with PCOS and obesity (2932)
Monitor blood glucose levels if sweating occurs, particularly if taking GLP-1 medications alongside insulin or sulfonylureas
(Of note, Life Extension is the only one of our milk thistle recommendations that specifies silybin content.) Whats more, the company that makes Siliphos, Indena, has conducted a handful of studies on it, which we cover in greater detail down in Life Extensions dedicated section
doi: 10.1016/j.jep.2021.114410 74 NotoAZahradkaPRyzNRYurkovaNXieXTaylorCG
For tirzepatide users, constipation management , diarrhea duration , and fatigue follow similar patterns
Nevertheless, the exact roles and regulatory mechanisms of circRNAs in IR require additional clarity